Intercept Pharmaceuticals Alternatives & Competitors
12 companies similar to Intercept Pharmaceuticals — Our mission is to build a healthier tomorrow for patients with rare and serious...
Companies similar to Intercept Pharmaceuticals
CymaBay Therapeutics
Dedicated to improving the lives of patients with liver diseases
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
HighTide Therapeutics
East Meets West—The Quest for Cure
AN2 Therapeutics
Developing therapies for rare, chronic, and serious infectious diseases
Rival Readout
Competing with Intercept Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Forma Therapeutics
Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...
Microbion Corporation
Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic,...
Atom Therapeutics
Atom Therapeutics Co., Ltd
Concortis Biosystems Corp
Innovative biotechnology driving advanced biotherapeutics with enhanced efficacy and reduc...
Xanthus Pharmaceuticals
Innovative treatments for cancer and autoimmune disorders through pioneering small-molecul...
Cyrus Therapeutics
Drugging the undruggable targets
About Intercept Pharmaceuticals
Intercept Pharmaceuticals, founded in 2002, is a biopharmaceutical company focused on developing novel therapeutics to treat rare and serious liver diseases such as primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). The company's last investment of $447.70M in Post-IPO Debt was made on 30...
Biopharmaceutical, Liver Diseases, Rare Diseases, Drug Development, Therapeutics, Chronic Autoimmune Liver Diseases, Small Molecule Drugs, Fibrotic Diseases, Metabolic Diseases, Bile Acid Receptors, Chronic Liver Diseases, Non-viral Liver Diseases, Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Intercept Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Intercept Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 1 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.